WILLIAM FLOWERS: Open Payments
NPI 1962855445 · JAMESTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,221 in 67 payments from 13 companies in 2025. Trend: 2023 $1,369 · 2024 $2,146 · 2025 $1,221
Food & beverage: $1,201Education: $20
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $271 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $204 |
| AstraZeneca Pharmaceuticals LP | 8 | $193 |
| ABBVIE INC. | 9 | $176 |
| Lilly USA, LLC | 4 | $81 |
| Corcept Therapeutics | 3 | $63 |
| Amgen Inc. | 4 | $59 |
| Phathom Pharmaceuticals, Inc. | 6 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
Products named: Kerendia, Ozempic, VRAYLAR, Rybelsus, FARXIGA, Korlym, AIRSUPRA, MOUNJARO.
Industry payments across TN — which companies pay providers there.
